Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ohm20's Profile
Displaying 1351-1400 of 6028 result(s).
CYDY CytoDyn Inc
08/09/2022 6:07:55 PM
Say a person has multiple issues, l (10)
CYDY CytoDyn Inc
07/28/2022 9:57:44 PM
It's still unknown what drug we wer (6)
CYDY CytoDyn Inc
07/28/2022 9:38:05 PM
a good bet we get a hook-up with gs (7)
CYDY CytoDyn Inc
07/28/2022 9:34:57 PM
Tandem approach?? "We have made so (10)
CYDY CytoDyn Inc
07/28/2022 9:25:49 PM
If the underlying cause of prostati (4)
CYDY CytoDyn Inc
07/28/2022 3:21:19 PM
Baldness and leronlimab I have alop (18)
CYDY CytoDyn Inc
07/28/2022 1:18:36 PM
Pfizer's danuglipron is an agonist (14)
SNPW Sun Pacific Holding Corp.
07/25/2022 4:24:22 PM
Great to see this very high value p
SNPW Sun Pacific Holding Corp.
07/25/2022 4:14:22 PM
Sure looks like Nick in that facili
CYDY CytoDyn Inc
07/24/2022 3:48:51 PM
But I think that purchasing entity (6)
CYDY CytoDyn Inc
07/22/2022 3:02:09 PM
As a surgeon, Bertagnolli specializ (10)
CYDY CytoDyn Inc
07/21/2022 11:59:41 AM
He is the author of What I've Learn (2)
CYDY CytoDyn Inc
07/20/2022 3:23:27 PM
I would not bet money on GSK doing (10)
CYDY CytoDyn Inc
07/20/2022 2:03:54 PM
A partnership would be the fastest (3)
CYDY CytoDyn Inc
07/20/2022 1:55:52 PM
If they are interested. Even in the (4)
CYDY CytoDyn Inc
07/20/2022 1:06:54 PM
GSK’s attention on two therapeuti (12)
CYDY CytoDyn Inc
07/20/2022 2:38:28 AM
Between the two I consider psilocyb (4)
CYDY CytoDyn Inc
07/19/2022 10:46:25 PM
t’s interesting that such a small (9)
CYDY CytoDyn Inc
07/19/2022 9:46:31 PM
I could set up a meth lab or an LSD (4)
CYDY CytoDyn Inc
07/19/2022 6:12:51 PM
Something I posted years ago that w (8)
CYDY CytoDyn Inc
07/18/2022 1:38:40 PM
Then why are you still here? You do (3)
CYDY CytoDyn Inc
07/18/2022 9:33:39 AM
High levels of M2 macrophages causi (1)
CYDY CytoDyn Inc
07/18/2022 9:22:20 AM
The hepatic expression levels of ge (2)
CYDY CytoDyn Inc
07/18/2022 2:37:17 AM
Maybe there is an upregulation in C (8)
CYDY CytoDyn Inc
07/17/2022 10:55:28 PM
I’m assuming the English translat (2)
CYDY CytoDyn Inc
07/17/2022 9:12:24 PM
So if Inflammation is what flips Ma (4)
CYDY CytoDyn Inc
07/17/2022 4:15:02 PM
The article states that in the proc (10)
CYDY CytoDyn Inc
07/17/2022 1:10:58 PM
Leronlimab is effective here in low (9)
CYDY CytoDyn Inc
07/16/2022 7:06:10 PM
Perhaps you should look on clinical (11)
CYDY CytoDyn Inc
07/16/2022 6:53:11 PM
Some loser said that Immunitybio wa (1)
CYDY CytoDyn Inc
07/16/2022 5:13:51 PM
when the douche bag moderators dele (13)
CYDY CytoDyn Inc
07/16/2022 4:56:16 PM
Remdesivir is useless. I said it wh (4)
CYDY CytoDyn Inc
07/16/2022 12:59:16 PM
Hey moron, nice to see you post. Bu (9)
CYDY CytoDyn Inc
07/16/2022 12:52:35 PM
"In October 2020, Emergent became o (11)
CYDY CytoDyn Inc
07/15/2022 10:22:24 AM
Are you all subject to some form of (12)
CYDY CytoDyn Inc
07/14/2022 4:01:15 PM
Compare and contrast the article by (4)
CYDY CytoDyn Inc
07/14/2022 1:06:37 AM
so ohm, what say you? Looking at th (14)
CYDY CytoDyn Inc
07/14/2022 12:50:43 AM
cancer patent ANTI-CCR5 AGENTS AND (4)
CYDY CytoDyn Inc
07/13/2022 5:35:37 PM
Someone asked me about Novavax a fe (2)
CYDY CytoDyn Inc
07/13/2022 5:23:16 PM
Thanks for posting a link to a good (18)
CYDY CytoDyn Inc
07/13/2022 12:49:52 PM
Both NASH and Longhaulers are unmet (7)
CYDY CytoDyn Inc
07/13/2022 7:44:45 AM
So, if I understand you correctly, (10)
CYDY CytoDyn Inc
07/12/2022 10:49:21 AM
Dostarlimab, a tremendously good PD (7)
CYDY CytoDyn Inc
07/11/2022 2:52:36 PM
Where there would be most benefit i (18)
CYDY CytoDyn Inc
07/10/2022 10:22:34 PM
Most likely referencing Patterson's (2)
CYDY CytoDyn Inc
07/10/2022 10:25:29 AM
Just 3 of the 89 indications would (16)
CYDY CytoDyn Inc
07/09/2022 1:01:42 AM
Correct, I should have actually wen (1)
CYDY CytoDyn Inc
07/09/2022 12:03:51 AM
How much does a major trial cost? P (4)
CYDY CytoDyn Inc
07/08/2022 11:58:05 PM
I'll be waiting for the new CEO to (4)
CYDY CytoDyn Inc
07/08/2022 11:55:58 PM
Is 350m enough to start/finish a tr (6)
Go to page:
  • << First
  • < Previous
  • 27
  • 28
  • Next >

Recent Articles

  • AMETEK Insider Sells $6.73 Million in Stock – A Look at Impact
  • Significant Criteo Stock Move by CFO Indicates Future Strategy
  • Eli Lilly's Verzenio Breakthrough: Transforming Breast Cancer Treatment
  • Market Reactions Post-Jackson Hole: A Closer Look at Treasuries
  • Analysts Favor CoreWeave and Other Stocks in New Ratings
  • Doodie-Calls Expands Its Reach with Heritage Sanitation Acquisition
  • Ambarella's Earnings Insights: What Investors Should Know
  • Insight Global Expands Operations with Over 10 Countries in LATAM
  • Fangzhou Inc. Achieves Record Growth and User Engagement in 2025
  • Rob Levine Law's Commitment to Safety with Free Ride Initiative
  • BICSI Establishes Saudi Arabia Affiliate for Digital Education
  • Criteo's Insider Trading Insights: What You Need to Know
  • Gentoo Media Leadership Boosts Stakeholding Confidence
  • Hampton Products International Welcomes New CCO Brent Flaharty
  • Gentoo Media Leadership Bolsters Shareholding Confidence
  • Experience the Thrill of Coinfest Asia 2025: A Crypto Festival Like No Other
  • Innovative Partnership Enhances Automotive Interior Experience
  • How Howmet Aerospace Stock Boosted Investor Returns Over Years
  • Tripti Sinha Takes the Helm as Internet2's New Leader
  • XRP's Upcoming Price Movements: Analyst Insights Revealed
  • Investigation of Charter Communications: What Investors Need to Know
  • Investors Alert: Class Action Lawsuits for RXST, RMHIX, FI, FLYW
  • Kohl's Surprises Investors with Impressive Earnings Report
  • Analyzing NVIDIA's Competitive Edge in Semiconductor Market
  • Evaluating Microsoft Against Major Software Industry Players
  • Insights into Meta Platforms and Its Competitors in Media
  • Understanding Frontline Inc.'s Stock Performance and Valuation
  • Comparative Industry Review: Amazon.com and Its Rivals
  • Understanding Apple's Position Among Hardware Competitors
  • Analyzing the Trends in Booking Holdings’ Options Market Activity
  • Understanding Recent Options Activity for Tesla Inc. (TSLA)
  • Navigating the Future of Zscaler: Options Insight and Performance
  • Rio Tinto's Strategic Restructure: A New Era Under Trott
  • Exciting Beginnings: Imagination Homes Launches First Community
  • Explore Solana's Potential: A Unique Investment Landscape
  • Harbour BioMed's Strong Interim Results Showcase Growth
  • Analyzing Ulta Beauty's Upcoming Earnings Report Insights
  • Important Update for CTO Realty Growth Investors – Act Now
  • Imagination Homes Sets New Standards in Affordable Living
  • Fusion Fuel Cycles Attracts Major Investment for Innovative Project
  • Looking Ahead: Iris Energy's Upcoming Earnings Insights
  • Power Solutions International Enhances Engine Offerings with HDI
  • Fullcast Merges with Atrium for Enhanced Sales Solutions
  • GIGA-42 Partners with Iceland for Advanced AI Data Centre
  • Global Endoscopic Submucosal Dissection Market Insights for Growth
  • Fortinet Achieves Leadership Status in 2025 Gartner Quadrant
  • Insightful Earnings Predictions for Bath & Body Works Ahead
  • PowerSecure Marks 25 Years of Innovative Energy Solutions
  • Check Point Software Technologies: Leading the Cybersecurity Front
  • Euronav's Earnings Report: What Investors Need to Know
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site